This company has been acquired
La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Taisho Pharmaceutical Holdings Crescita futura
Future criteri di controllo 3/6
Taisho Pharmaceutical Holdings is forecast to grow earnings and revenue by 23.7% and 3.2% per annum respectively. EPS is expected to grow by 23.7% per annum. Return on equity is forecast to be 2.8% in 3 years.
Informazioni chiave
23.7%
Tasso di crescita degli utili
23.7%
Tasso di crescita dell'EPS
Pharmaceuticals crescita degli utili | 23.7% |
Tasso di crescita dei ricavi | 3.2% |
Rendimento futuro del capitale proprio | 2.8% |
Copertura analitica | Low |
Ultimo aggiornamento | 13 Feb 2024 |
Aggiornamenti recenti sulla crescita futura
Recent updates
Previsioni di crescita degli utili e dei ricavi
Data | Ricavi | Guadagni | Flusso di cassa libero | Liquidità dell'operazione | Avg. Numero di analisti |
---|---|---|---|---|---|
3/31/2027 | 356,300 | 23,800 | N/A | N/A | 1 |
3/31/2026 | 329,100 | 18,250 | N/A | N/A | 2 |
3/31/2025 | 326,250 | 18,100 | 56,850 | N/A | 2 |
3/31/2024 | 318,500 | 9,300 | 46,380 | N/A | 1 |
12/31/2023 | 320,385 | 8,421 | N/A | N/A | N/A |
9/30/2023 | 319,960 | 15,570 | -23,549 | 19,217 | N/A |
6/30/2023 | 313,114 | 17,609 | N/A | N/A | N/A |
3/31/2023 | 301,381 | 18,997 | -9,407 | 40,972 | N/A |
12/31/2022 | 295,821 | 25,047 | N/A | N/A | N/A |
9/30/2022 | 282,560 | 21,091 | 4,278 | 29,052 | N/A |
6/30/2022 | 273,388 | 17,694 | N/A | N/A | N/A |
3/31/2022 | 268,203 | 13,122 | 14,117 | 28,506 | N/A |
12/31/2021 | 267,731 | 8,055 | N/A | N/A | N/A |
9/30/2021 | 266,241 | 4,930 | 23,057 | 36,713 | N/A |
6/30/2021 | 270,841 | 8,431 | N/A | N/A | N/A |
3/31/2021 | 281,980 | 13,316 | 27,654 | 42,026 | N/A |
12/31/2020 | 291,489 | 16,837 | N/A | N/A | N/A |
9/30/2020 | 302,219 | 16,846 | 27,145 | 38,788 | N/A |
6/30/2020 | 303,290 | 15,589 | N/A | N/A | N/A |
3/31/2020 | 288,527 | 20,531 | 32,871 | 41,992 | N/A |
12/31/2019 | 272,993 | 15,124 | N/A | N/A | N/A |
9/30/2019 | 264,268 | 21,138 | 19,814 | 25,986 | N/A |
6/30/2019 | 260,063 | 45,910 | N/A | N/A | N/A |
3/31/2019 | 261,551 | 48,593 | 14,308 | 19,222 | N/A |
12/31/2018 | 264,190 | 56,614 | N/A | N/A | N/A |
9/30/2018 | 270,953 | 62,097 | 44,007 | 48,653 | N/A |
6/30/2018 | 273,308 | 39,834 | N/A | N/A | N/A |
3/31/2018 | 280,092 | 31,679 | 34,839 | 39,852 | N/A |
12/31/2017 | 279,140 | 31,574 | N/A | N/A | N/A |
9/30/2017 | 277,396 | 27,298 | N/A | 29,157 | N/A |
6/30/2017 | 278,874 | 27,370 | N/A | N/A | N/A |
3/31/2017 | 279,773 | 28,781 | N/A | 40,066 | N/A |
12/31/2016 | 281,588 | 27,438 | N/A | N/A | N/A |
9/30/2016 | 285,158 | 24,691 | N/A | 42,280 | N/A |
6/30/2016 | 290,354 | 24,732 | N/A | N/A | N/A |
3/31/2016 | 290,135 | 22,473 | N/A | 43,058 | N/A |
12/31/2015 | 293,717 | 23,594 | N/A | N/A | N/A |
9/30/2015 | 294,677 | 23,217 | N/A | 37,255 | N/A |
6/30/2015 | 291,339 | 22,556 | N/A | N/A | N/A |
3/31/2015 | 290,498 | 24,529 | N/A | 33,715 | N/A |
12/31/2014 | 289,777 | 24,493 | N/A | N/A | N/A |
9/30/2014 | 293,199 | 28,769 | N/A | 44,669 | N/A |
6/30/2014 | 296,150 | 31,940 | N/A | N/A | N/A |
3/31/2014 | 295,958 | 32,693 | N/A | 60,233 | N/A |
12/31/2013 | 292,838 | 32,311 | N/A | N/A | N/A |
9/30/2013 | 289,779 | 30,170 | N/A | 48,360 | N/A |
6/30/2013 | 285,573 | 26,139 | N/A | N/A | N/A |
Previsioni di crescita futura degli analisti
Guadagni vs tasso di risparmio: TAIS.F's forecast earnings growth (23.7% per year) is above the savings rate (2.3%).
Guadagni vs Mercato: TAIS.F's earnings (23.7% per year) are forecast to grow faster than the US market (13.4% per year).
Guadagni ad alta crescita: TAIS.F's earnings are expected to grow significantly over the next 3 years.
Ricavi vs Mercato: TAIS.F's revenue (3.2% per year) is forecast to grow slower than the US market (8.2% per year).
Ricavi ad alta crescita: TAIS.F's revenue (3.2% per year) is forecast to grow slower than 20% per year.
Previsioni di crescita dell'utile per azione
Rendimento futuro del capitale proprio
ROE futuro: TAIS.F's Return on Equity is forecast to be low in 3 years time (2.8%).